Key Insights
The European pharmaceutical glass vials and ampoules market, valued at approximately €800 million in 2025, is projected to experience robust growth, driven by a Compound Annual Growth Rate (CAGR) of 5.42% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of injectable pharmaceuticals, particularly biologics and vaccines, necessitates a higher demand for glass vials and ampoules, which offer superior inertness and barrier properties compared to alternative packaging materials. Furthermore, stringent regulatory requirements regarding pharmaceutical packaging safety and quality standards are driving manufacturers to adopt high-quality glass containers, further boosting market growth. Growing investments in research and development within the pharmaceutical industry, especially in advanced drug delivery systems, contribute to the overall demand for specialized glass vials and ampoules. The market is also witnessing a rise in the adoption of sustainable and eco-friendly packaging solutions, pushing manufacturers to innovate and produce environmentally responsible glass containers. The competitive landscape includes established players like Schott, Gerresheimer, and Stevanato Group, who are actively engaged in expanding their production capacities and product portfolios to meet the rising market demands.
Europe Pharmaceutical Glass Vials And Ampoules Market Market Size (In Million)
Geographical segmentation reveals a varied market share across European nations, with Germany, France, and the United Kingdom likely representing significant market segments. However, the provided data lacks specific regional breakdowns. The market is segmented based on vial type (clear, amber, etc.), capacity, and application (vaccines, injectables, etc.), providing opportunities for specialized product offerings and niche market penetration. Challenges to growth may include fluctuations in raw material prices, potential supply chain disruptions, and the increasing competition from alternative packaging materials such as plastic. Nevertheless, the long-term growth outlook for the European pharmaceutical glass vials and ampoules market remains positive, underpinned by the continuous advancements in the pharmaceutical industry and the growing demand for safe and effective injectable medications.
Europe Pharmaceutical Glass Vials And Ampoules Market Company Market Share
Europe Pharmaceutical Glass Vials and Ampoules Market: A Comprehensive Report (2019-2033)
This detailed report provides a comprehensive analysis of the Europe Pharmaceutical Glass Vials and Ampoules Market, offering invaluable insights for industry stakeholders. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report leverages historical data (2019-2024) to project future market trends and opportunities. The report meticulously examines market dynamics, competitive landscapes, and growth drivers, providing actionable strategies for informed decision-making.
Europe Pharmaceutical Glass Vials And Ampoules Market Market Structure & Competitive Dynamics
The European pharmaceutical glass vials and ampoules market is characterized by a moderately concentrated structure, with several key players commanding significant market share. While precise market share figures for individual companies are proprietary data (xx%), leading companies like Gerresheimer AG, Stevanato Group, SGD S A, and DWK Life Sciences exhibit strong market presence. The competitive landscape is dynamic, influenced by factors such as:
- Market Concentration: The market is neither highly fragmented nor dominated by a single player, allowing for both competition and collaboration amongst leading players.
- Innovation Ecosystems: Companies continuously invest in R&D to develop novel glass formulations, improved manufacturing processes, and enhanced functionalities, including pre-filled syringes.
- Regulatory Frameworks: Stringent regulatory compliance requirements and quality standards for pharmaceutical packaging significantly impact market dynamics. Compliance necessitates high capital investment and expertise in quality control.
- Product Substitutes: While glass remains the dominant material, competition arises from alternative packaging materials like plastic, particularly for certain applications. This substitution represents a continuous challenge that demands glass manufacturers to showcase continuous innovation and value-added services.
- End-User Trends: The demand for pharmaceutical glass vials and ampoules is directly correlated with the growth of the pharmaceutical industry, particularly the injectable drug sector. The increasing prevalence of chronic diseases and the rising geriatric population further fuels demand.
- M&A Activities: Recent M&A activity showcases industry consolidation and strategic expansion. The acquisition of Bormioli Pharma by Gerresheimer (USD 883.24 Million) exemplifies this trend. This deal significantly expands Gerresheimer’s European footprint and strengthens its position as a full-service provider.
Europe Pharmaceutical Glass Vials And Ampoules Market Industry Trends & Insights
The European pharmaceutical glass vials and ampoules market is experiencing robust growth, driven by several key factors. The Compound Annual Growth Rate (CAGR) is estimated to be xx% during the forecast period (2025-2033), largely influenced by:
- Market Growth Drivers: The expanding pharmaceutical industry, the rising prevalence of chronic diseases demanding injectable medications, and the increasing demand for pre-filled syringes contribute significantly to the market's growth. Furthermore, the market penetration of advanced therapies requiring specialized vials is further accelerating the growth.
- Technological Disruptions: Innovations in glass manufacturing technology, particularly the adoption of automated processes and advanced quality control systems, enhance production efficiency and product quality. Furthermore, the introduction of specialized glass formulations for improved drug stability and compatibility are changing market dynamics.
- Consumer Preferences: While the end-consumer does not directly interact with vials, their indirect preferences through drug companies determine market trends. The trend toward enhanced drug stability, extended shelf life, and ease of administration directly influences demand.
- Competitive Dynamics: The competitive dynamics in the market are characterized by a combination of competition based on pricing, product quality, and innovation, further driving growth via improvement in the quality and innovation in the products. The market's concentration and the ongoing M&A activities suggest a mature but constantly evolving market. Market penetration of different types of vials, based on functionalities and material properties, is also a major driver of growth.
Dominant Markets & Segments in Europe Pharmaceutical Glass Vials And Ampoules Market
The Western European region dominates the market, particularly countries like Germany, France, and Italy. This dominance is attributed to:
Key Drivers:
- Developed Healthcare Infrastructure: Advanced healthcare infrastructure and robust pharmaceutical industries in these countries stimulate demand for high-quality packaging solutions.
- Favorable Economic Conditions: Strong economic performance ensures sustained healthcare spending and pharmaceutical investment.
- Stringent Regulatory Standards: Enforcing stringent quality and regulatory compliance standards boosts adoption of premium, high-quality glass vials.
Dominance Analysis: The high concentration of pharmaceutical companies, research institutions, and manufacturing facilities within Western European countries contributes significantly to the elevated demand for pharmaceutical packaging solutions. Germany's robust chemical and manufacturing sectors particularly support the growth within this market.
Europe Pharmaceutical Glass Vials And Ampoules Market Product Innovations
Recent years have witnessed significant product innovation, including the development of specialized glass vials with enhanced barrier properties for improved drug stability, and the adoption of advanced surface treatment technologies to improve compatibility with various drug formulations. These innovations offer competitive advantages by enhancing product quality, extending shelf life, and improving drug efficacy. Furthermore, the integration of smart packaging features is enhancing the safety and security of drug distribution.
Report Segmentation & Scope
This report segments the market based on several crucial parameters:
- By Product Type: Glass vials and ampoules are categorized further by capacity (e.g., 1ml, 2ml, 10ml, etc.) and color (clear or amber). Each segment exhibits a specific growth projection and competitive dynamics based on demand and technological advancement. Market sizes for each segment are detailed in the main report.
- By Application: The market is segmented by pharmaceutical drug type, including injectables, vaccines, and other parenteral medications. Different drug types have specific vial requirements based on stability and compatibility. Detailed analysis of each application is provided.
- By End-User: The report analyzes the market based on end-users, including pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and hospitals. Each user category exhibits a varying demand based on scale and need. Market size for each is projected in the main report.
Key Drivers of Europe Pharmaceutical Glass Vials And Ampoules Market Growth
Several factors contribute to the market's growth trajectory:
- Technological Advancements: Innovation in glass manufacturing technology, automated processes, and enhanced quality control systems are key to improvement in quality, efficiency and cost reduction.
- Economic Growth: Steady economic growth across Europe fuels investment in healthcare infrastructure and consequently in high-quality packaging materials.
- Government Regulations: Stringent regulations ensure high product quality and patient safety, driving demand for compliant packaging solutions.
Challenges in the Europe Pharmaceutical Glass Vials And Ampoules Market Sector
The market faces certain challenges:
- Regulatory Hurdles: Complying with stringent regulatory standards and gaining approvals necessitate considerable investment and expertise, increasing costs for manufacturing firms.
- Supply Chain Disruptions: Global supply chain uncertainties can impact the availability of raw materials and affect production.
- Competitive Pressure: The market's competitive nature requires companies to continuously innovate and enhance operational efficiencies to maintain market share.
Leading Players in the Europe Pharmaceutical Glass Vials And Ampoules Market Market
- Scott Pharma (Scott AG)
- Gerresheimer AG
- Stevanato Group
- SGD S A
- DWK Life Sciences
- Bormioli Pharma S p A
- NAFVSM B V
- Soffieria Bertolini S p A
- SFAM Group
- Origin Pharma Packaging
- Alphial S r l
- *List Not Exhaustive
Key Developments in Europe Pharmaceutical Glass Vials And Ampoules Market Sector
- May 2024: Gerresheimer AG's acquisition of Bormioli Pharma for USD 883.24 Million significantly expands its European market presence and strengthens its position as a full-service provider.
- January 2024: SGD Pharma's new siliconization line boosts its capacity for siliconized glass vials, enhancing its supply chain efficiency and responsiveness.
Strategic Europe Pharmaceutical Glass Vials And Ampoules Market Market Outlook
The European pharmaceutical glass vials and ampoules market presents significant growth potential driven by continuous innovation, expanding pharmaceutical applications, and the increasing demand for high-quality packaging solutions. Strategic opportunities exist for companies focusing on customized packaging solutions, enhanced quality control processes, and sustainable manufacturing practices. Further growth is expected through partnerships with pharmaceutical companies and advancements in specialty glass formulations.
Europe Pharmaceutical Glass Vials And Ampoules Market Segmentation
-
1. Product Type
- 1.1. Vials
- 1.2. Ampoules
-
2. Geography***
- 2.1. Germany
- 2.2. Italy
- 2.3. France
- 2.4. United Kingdom
- 2.5. Spain
Europe Pharmaceutical Glass Vials And Ampoules Market Segmentation By Geography
- 1. Germany
- 2. Italy
- 3. France
- 4. United Kingdom
- 5. Spain
Europe Pharmaceutical Glass Vials And Ampoules Market Regional Market Share
Geographic Coverage of Europe Pharmaceutical Glass Vials And Ampoules Market
Europe Pharmaceutical Glass Vials And Ampoules Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.42% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities
- 3.3. Market Restrains
- 3.3.1. Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities
- 3.4. Market Trends
- 3.4.1. Ampoules Are Set To Hold Significant Market Share
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 5.1.1. Vials
- 5.1.2. Ampoules
- 5.2. Market Analysis, Insights and Forecast - by Geography***
- 5.2.1. Germany
- 5.2.2. Italy
- 5.2.3. France
- 5.2.4. United Kingdom
- 5.2.5. Spain
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Germany
- 5.3.2. Italy
- 5.3.3. France
- 5.3.4. United Kingdom
- 5.3.5. Spain
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 6. Germany Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 6.1.1. Vials
- 6.1.2. Ampoules
- 6.2. Market Analysis, Insights and Forecast - by Geography***
- 6.2.1. Germany
- 6.2.2. Italy
- 6.2.3. France
- 6.2.4. United Kingdom
- 6.2.5. Spain
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 7. Italy Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 7.1.1. Vials
- 7.1.2. Ampoules
- 7.2. Market Analysis, Insights and Forecast - by Geography***
- 7.2.1. Germany
- 7.2.2. Italy
- 7.2.3. France
- 7.2.4. United Kingdom
- 7.2.5. Spain
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 8. France Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 8.1.1. Vials
- 8.1.2. Ampoules
- 8.2. Market Analysis, Insights and Forecast - by Geography***
- 8.2.1. Germany
- 8.2.2. Italy
- 8.2.3. France
- 8.2.4. United Kingdom
- 8.2.5. Spain
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 9. United Kingdom Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 9.1.1. Vials
- 9.1.2. Ampoules
- 9.2. Market Analysis, Insights and Forecast - by Geography***
- 9.2.1. Germany
- 9.2.2. Italy
- 9.2.3. France
- 9.2.4. United Kingdom
- 9.2.5. Spain
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 10. Spain Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Product Type
- 10.1.1. Vials
- 10.1.2. Ampoules
- 10.2. Market Analysis, Insights and Forecast - by Geography***
- 10.2.1. Germany
- 10.2.2. Italy
- 10.2.3. France
- 10.2.4. United Kingdom
- 10.2.5. Spain
- 10.1. Market Analysis, Insights and Forecast - by Product Type
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Scott Pharma (Scott AG)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Gerresheimer AG
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Stevanato Group
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 SGD S A
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 DWK Life Sciences
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Bormioli Pharma S p A
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 NAFVSM B V
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Soffieria Bertolini S p A
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 SFAM Group
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Origin Pharma Packaging
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Alphial S r l *List Not Exhaustive 7 2 Heat Map Analysi
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Scott Pharma (Scott AG)
List of Figures
- Figure 1: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: Europe Pharmaceutical Glass Vials And Ampoules Market Share (%) by Company 2025
List of Tables
- Table 1: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 2: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 3: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 4: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 5: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Region 2020 & 2033
- Table 6: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Region 2020 & 2033
- Table 7: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 8: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 9: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 10: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 11: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 12: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 13: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 14: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 15: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 16: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 17: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 18: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 19: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 20: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 21: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 22: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 23: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 24: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 25: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 26: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 27: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 28: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 29: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 31: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 32: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 33: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 34: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 35: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 36: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Glass Vials And Ampoules Market?
The projected CAGR is approximately 5.42%.
2. Which companies are prominent players in the Europe Pharmaceutical Glass Vials And Ampoules Market?
Key companies in the market include Scott Pharma (Scott AG), Gerresheimer AG, Stevanato Group, SGD S A, DWK Life Sciences, Bormioli Pharma S p A, NAFVSM B V, Soffieria Bertolini S p A, SFAM Group, Origin Pharma Packaging, Alphial S r l *List Not Exhaustive 7 2 Heat Map Analysi.
3. What are the main segments of the Europe Pharmaceutical Glass Vials And Ampoules Market?
The market segments include Product Type, Geography***.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.8 Million as of 2022.
5. What are some drivers contributing to market growth?
Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities.
6. What are the notable trends driving market growth?
Ampoules Are Set To Hold Significant Market Share.
7. Are there any restraints impacting market growth?
Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities.
8. Can you provide examples of recent developments in the market?
May 2024: Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, inked a purchase agreement with funds advised by Triton ("Triton") to acquire Blitz LuxCo Sarl, the holding entity of the Bormioli Pharma Group ("Bormioli Pharma"). The agreed purchase price hinges on an enterprise value pegged at approximately EUR 800 million (USD 883.24 million). Bormioli Pharma's diverse portfolio encompasses pharmaceutical primary packaging crafted from both glass and plastic, alongside closure solutions, accessories, and dispensing systems. Through this acquisition, Gerresheimer bolsters its presence in Europe, particularly in Southern regions, and solidifies its stature as a premier full-service provider and global ally to the pharmaceutical and biotech sectors.January 2024: SGD Pharma boosted capacity for siliconized glass vials with a new line. The company inaugurated a new siliconisation operation at its Saint-Quentin Lamotte (SQLM) facility in France. By bringing glass silicification in-house, the company bolsters its already comprehensive suite of services, ensuring quicker responses, a secure supply chain, and greater flexibility in vial sizes. The newly established operation at SQLM can handle all glass types, accommodating vial sizes from 3 ml to 500 ml in both clear and amber variants, all while maintaining a high processing capacity. This treatment caters to diverse market needs, including applications in anti-infectives, parenteral nutrition, diagnostics, animal health, and oncology.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Glass Vials And Ampoules Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Glass Vials And Ampoules Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Glass Vials And Ampoules Market?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Glass Vials And Ampoules Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence